Organization: Centre for Drug Research and Development

Kairos and Zymeworks complete merger

Kairos Therapeutics Inc — a spin off of the Centre for Drug Research and Development — has completed its merger with Zymeworks Inc (R$, January 26/16). The merger will allow the Vancouver-based biotherapeutics companies to accelerate their respective platforms, resources and pipelines….

Biotech partnership may lead to merger

Two privately held Vancouver biotech firms have entered a strategic partnership that could lead to an eventual merger. Zymeworks Inc has made an equity investment in Kairos Therapeutics Inc — a spin off of the Centre for Drug Research and Development. Zymeworks specializes in bi-specific and multi-specific anybodies while Cairos discovers and develops antibody drug…

Vida and CDRD collaborate on drug development

Privately held Vida Therapeutics Inc is collaborating with the Centre for Drug Research and Development (CDRD) to advance its lead drug candidate to the commercial stage and position the firm for further private sector investment. CDRD synthesized and supplied the GzmB inhibitor drug compound to be used as a target for Vida’s therapeutic strategy. The…

CDRD scores $2.2 million for immunotherapy equipment

Western Economic Diversification (WD) is providing $2.2 million to the Centre for Drug Research and Development to purchase equipment for its new immunotherapy initiative. The equipment will allow CDRD to work with academic researchers and companies to develop novel technologies and potentially identify new targets for immunotherapy. The funding builds on a $900,000 WD investment…

CDRD scores $2.2 million for immunotherapy equipment

Western Economic Diversification (WD) is providing $2.2 million to the Centre for Drug Research and Development to purchase equipment for its new immunotherapy initiative. The equipment will allow CDRD to work with academic researchers and companies to develop novel technologies and potentially identify new targets for immunotherapy. The funding builds on a $900,000 WD investment…

CDRD collaborates with Saskatchewan consortium

The Centre for Drug Research and Development (CDRD) has teamed with a consortium of Saskatchewan-based organizations to establish the CDRD-Saskatchewan Innovation Fund for accelerating the commercialization of health discoveries emanating from the province’s research institutions. CDRD is committing $1 million to be matched by a consortium comprised of the Univ of Saskatchewan‘s College of Pharmacy…

CDRD collaborates with Saskatchewan consortium

The Centre for Drug Research and Development (CDRD) has teamed with a consortium of Saskatchewan-based organizations to establish the CDRD-Saskatchewan Innovation Fund for accelerating the commercialization of health discoveries emanating from the province’s research institutions. CDRD is committing $1 million to be matched by a consortium comprised of the Univ of Saskatchewan‘s College of Pharmacy…

CAIP awards $10.9 million to CDRD and CVI

The Centre for Drug Research and Development (CDRD) and its commercialization arm — CDRD Ventures Inc — have received $10.9 million from the Canada Accelerator and Incubator Program (CAIP). CDRD will use the funding to incubate firms by helping to de-risking discoveries derived from publicly funded health research and making early-stage research more investment ready.…

CDRD signs affiliation with Univ of Manitoba

The Vancouver-based Centre for Drug Research and Development (CDRD) has signed an affiliation agreement with the Univ of Manitoba, building on a previous collaboration with the St Boniface Hospital Research centre. The agreement expands CDRD’s active collaborations to eight provinces for commercializing small molecule and biologic therapeutics. It will assist U of M faculty members…

CDRD establishes Atlantic Research Node

Vancouver-based Centre for Drug Research and Development (CDRD) has established the first in a proposed pan-Canadian network of research nodes with an agreement to collaborate with Dalhousie Univ and the IWK Health Centre, both in Halifax. The CDRD Atlantic Research Node will initially be focused on zebrafish models of disease and leverage the research of…